Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Medi Line Active Korea Co. Ltd. operates a patent portfolio within the Medical Devices & Mechanical Engineering technology area. The data shows 1 pending office action, which is the active prosecution matter for the company at this time. This action is assigned to 1 distinct examiner, creating a centralized review process. For the applicant, this means that the immediate future of their intellectual property depends on the interpretation of a particular USPTO official for Medi Line Active Korea Co. Ltd.
The prosecution is currently confined to the distinct art unit. PATEL, SHEFALI DILIP is the busiest examiner for Medi Line Active Korea Co. Ltd., with the busiest examiner pending office action. Because this action constitutes the company's pending workload, the examiner's history and tendencies in the Medical Devices & Mechanical Engineering field are the primary considerations for the strategy. The alignment of the pending action with the examiner and the art unit indicates the prosecution path for Medi Line Active Korea Co. Ltd.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PATEL, SHEFALI DILIP | 1 | 58.0% | +27.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17911154 | FLOW RATE CONTROL REGULATOR FOR FLUID INFUSION | PATEL, SHEFALI DILIP | 15d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17911154 | FLOW RATE CONTROL REGULATOR FOR FLUID INFUSION | PATEL, SHEFALI DILIP | 15d |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17911154 | FLOW RATE CONTROL REGULATOR FOR FLUID INFUSION | PATEL, SHEFALI DILIP | 3783 | §103§112 | Non-Final OA | 15d | Pending | Sep 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial